merck news


Latest from merck

Indian firm launches Merck’s Covid pill under brand name ‘molulife’

Over a dozen Indian companies have publicly stated they will produce the pill, the patent for which was freed for low- and middle-income countries by the American pharma firm under the United Nations Medicines Patent Pool.

A health worker administers Covid-19 vaccine to a beneficiary at Chembur Vaccination center in Mumbai on Wednesday. (Satish Bate/HT Photo)
Updated on Dec 30, 2021 04:31 AM IST

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report

The UK approved Molnupiravir In November. It was one of the first nations to approve the oral pill to treat patients suffering from mild to moderate Covid-19.

Merck’s antiviral pill was found to be 30% effective at reducing risk of hospitalization and death in high-risk people.(Reuters)
Published on Dec 05, 2021 02:58 PM IST

US panel backs Merck's first-of-a-kind Covid-19 pill 

The drug, molnupiravir, could provide a much-needed weapon against the virus as colder weather pushes case counts higher and US officials brace for the arrival of the new omicron variant.

The pill is already authorized in the UK.(via REUTERS)
Updated on Dec 01, 2021 10:45 AM IST
AP |

Merck asks EU drug regulator to authorise its Covid-19 pill

In a statement Tuesday, the European Medicines Agency said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared.

EMA said the drug should be given as soon as possible after Covid-19 has been diagnosed and within five days of symptoms starting.(Reuters)
Updated on Nov 24, 2021 12:20 AM IST
PTI | By, Amsterdam

UK becomes first country to approve Merck's  anti-Covid pill molnupiravir

The antiviral, called molnupiravir, works by decreasing the ability of a virus to replicate, thereby slowing down the disease.

Based on the clinical trial data, the drug is most effective when taken during the early stages of infection and the MHRA recommends that it be used within five days of the onset of symptoms.(AFP)
Published on Nov 04, 2021 05:31 PM IST

Experts laud Merck's Covid-19 drug molnupiravir. All you need to know

Molnupiravir is designed to introduce errors into the genetic code of the virus and would be the first oral antiviral medication for Covid-19

The experimental drug, molnupiravir, significantly reduced the risk of hospitalization or death when administered to high-risk patients early in the disease, Merck and its partner Ridgeback Biotherapeutics said in a statement.(via REUTERS)
Published on Oct 02, 2021 08:17 PM IST
Written by Shankhyaneel Sarkar | Edited by Poulomi Ghosh, Hindustan Times, New Delhi

Merck to help make Johnson & Johnson's single-shot Covid-19 vaccine: Report

US-based Merck halted the development of two of its own coronavirus vaccines in January to instead focus on its two Covid-19 treatments.

The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US.(REUTERS)
Published on Mar 02, 2021 07:29 PM IST
Reuters | | Posted by Kunal Gaurav
Story Saved
Live Score
Saved Articles
My Reads
My Offers
Sign out
New Delhi 0C
Thursday, June 01, 2023
Start 14 Days Free Trial Subscribe Now
Register Free and get Exciting Deals